Skip to main content

Alimera Exhibits Continued Growth and Expansion With New Branding and Office Relocation

ATLANTA, April 06, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that the company launched new corporate branding and has moved its global headquarters to a new, state-of-the-art facility.

Alimera refreshed its corporate brand for the first time in the company’s two-decade history to better represent its current business focus and identity – approachable, energetic, and collaborative. The new logo includes the Alimera “eyecon” which is two lowercase ‘A’s coming together to form an eye, symbolizing Alimera coming together with retina specialists and partners to provide better solutions for patients. The modern design consists of a bold dark blue with a teal accent to reflect Alimera’s main product, ILUVIEN®. The updated company tagline “We see more, together” epitomizes Alimera’s mission to continue to positively impact the standard of care for retina patients worldwide.

“It is important that our brand accurately portrays our business and our passion for preserving patient vision,” said Chief Marketing Officer, Dave Holland. “We are continually seeking new and innovative ways to work together with providers, patients, and partners in the retina space to achieve this.”

In tandem with their rebrand initiative, Alimera has also relocated to a new global headquarters. The company is the first corporate tenant to take occupancy in Building 1100 at Halcyon, an idyllic yet energetic 135-acre mixed-use development in Forsyth County, just north of Atlanta, Georgia. In addition to corporate suites, the community destination hosts a variety of shops, restaurants, residences, and creative loft offices. The development is built with a common green space at its center and includes direct access to Big Creek Greenway. Alimera’s new corporate space was designed to align with the Alimera culture and consists of an ecosystem of workspace options including open workstations, enclosed focus and huddle rooms, and a social café with booths and banquettes to encourage camaraderie, while providing productive workspace choices for employees.

“Since Alimera was founded nearly 20 years ago, our business model has evolved from a broad ophthalmology company to an organization that is focused on serving the retina community, patients, and physicians alike,” said President and Chief Executive Officer, Rick Eiswirth. “Our new corporate headquarters is ideally suited for collaborative cross-functional work to better serve our customers. We remain committed to Alimera’s global expansion and look forward to our continued growth and greater impact in the retina space.”

About Alimera

www.alimerasciences.com

Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:
Cassy Dump
for Alimera
619-971-1887
cassy.dump@precisionvh.com 
For investor inquiries:
Scott Gordon
for Alimera
scottg@coreir.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.